These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28365393)

  • 21. Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria.
    Turner N; Wong HL; Templeton A; Tripathy S; Whiti Rogers T; Croxford M; Jones I; Sinnathamby M; Desai J; Tie J; Bae S; Christie M; Gibbs P; Tran B
    Int J Cancer; 2016 Feb; 138(3):671-8. PubMed ID: 26270488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer.
    Patel M; McSorley ST; Park JH; Roxburgh CSD; Edwards J; Horgan PG; McMillan DC
    Br J Cancer; 2018 Mar; 118(5):705-712. PubMed ID: 29337962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients.
    Bozkurt O; Karaca H; Berk V; Inanc M; Ocak Duran A; Ozaslan E; Ucar M; Ozkan M
    J BUON; 2015; 20(6):1432-9. PubMed ID: 26854438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.
    Ethier JL; Desautels D; Templeton A; Shah PS; Amir E
    Breast Cancer Res; 2017 Jan; 19(1):2. PubMed ID: 28057046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Stage I-II Rectal Cancer Patients.
    Yoshida D; Minami K; Sugiyama M; Ota M; Ikebe M; Morita M; Matsukuma A; Toh Y
    J Surg Res; 2020 Jan; 245():281-287. PubMed ID: 31421374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancer.
    Liu Q; Ma Y; Luo D; Cai S; Li Q; Li X
    Int J Colorectal Dis; 2018 Aug; 33(8):1107-1114. PubMed ID: 29770845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Performance of a New Staging Category to Improve Discrimination of Disease-Specific Survival in Nonmetastatic Oral Cancer.
    Lee CC; Huang CY; Lin YS; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; Chen HC; Yang CC
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):395-402. PubMed ID: 28125757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.
    Hung HY; Chen JS; Yeh CY; Changchien CR; Tang R; Hsieh PS; Tasi WS; You JF; You YT; Fan CW; Wang JY; Chiang JM
    Int J Colorectal Dis; 2011 Aug; 26(8):1059-65. PubMed ID: 21479566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Significance of Neutrophil-to-lymphocyte Ratio in the Framework of the 8th TNM Edition for Breast Cancer.
    Ferroni P; Roselli M; Buonomo OC; Spila A; Portarena I; Laudisi A; Valente MG; Pirillo SP; Fortunato L; Costarelli L; Cavaliere F; Guadagni F
    Anticancer Res; 2018 Aug; 38(8):4705-4712. PubMed ID: 30061239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
    Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
    BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis.
    Mazaki J; Katsumata K; Kasahara K; Tago T; Wada T; Kuwabara H; Enomoto M; Ishizaki T; Nagakawa Y; Tsuchida A
    BMC Cancer; 2020 Sep; 20(1):922. PubMed ID: 32977767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.
    Thirunavukarasu P; Talati C; Munjal S; Attwood K; Edge SB; Francescutti V
    JAMA Surg; 2015 Aug; 150(8):747-755. PubMed ID: 26083632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of preoperative fibrinogen in patients with colon cancer.
    Sun ZQ; Han XN; Wang HJ; Tang Y; Zhao ZL; Qu YL; Xu RW; Liu YY; Yu XB
    World J Gastroenterol; 2014 Jul; 20(26):8583-91. PubMed ID: 25024612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer.
    Hong J; Mao Y; Chen X; Zhu L; He J; Chen W; Li Y; Lin L; Fei X; Shen K
    Tumour Biol; 2016 Mar; 37(3):4135-42. PubMed ID: 26490984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer.
    Ding PR; An X; Zhang RX; Fang YJ; Li LR; Chen G; Wu XJ; Lu ZH; Lin JZ; Kong LH; Wan DS; Pan ZZ
    Int J Colorectal Dis; 2010 Dec; 25(12):1427-33. PubMed ID: 20821217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer.
    Yu L; Lv CY; Yuan AH; Chen W; Wu AW
    World J Gastroenterol; 2015 May; 21(20):6280-6. PubMed ID: 26034363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study.
    Taylor FG; Quirke P; Heald RJ; Moran BJ; Blomqvist L; Swift IR; Sebag-Montefiore D; Tekkis P; Brown G;
    J Clin Oncol; 2014 Jan; 32(1):34-43. PubMed ID: 24276776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
    Wu S; Zhao X; Wang Y; Zhong Z; Zhang L; Cao J; Ai K; Xu R
    Cell Physiol Biochem; 2018; 46(4):1352-1364. PubMed ID: 29689562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.